S. Reynisdottir et al., EFFECTS OF WEIGHT-REDUCTION ON THE REGULATION OF LIPOLYSIS IN ADIPOCYTES OF WOMEN WITH UPPER-BODY OBESITY, Clinical science, 89(4), 1995, pp. 421-429
1. The regulation of lipolysis was studied in 14 upper-body obese wome
n aged 26-55 years. Isolated subcutaneous adipocytes from the abdomina
l region were examined before and after an 8 to 12-week-long weight re
duction programme, during which the mean body mass index (kg/m(2)) of
the group was reduced from 36.4 +/- 0.9 to 30.3 +/- 1.0. 2. Fat cell v
olume was reduced from 891 +/- 39 to 655 +/- 45 pl, The sensitivity to
noradrenaline stimulation of lipolysis in vitro increased fivefold af
ter weight reduction, A corresponding increase in sensitivity was foun
d with the beta(2)-selective adrenoceptor agonist terbutaline. However
, the number of beta(2)-adrenoceptor binding sites as assessed by radi
oligand binding with I-125-labelled cyanopindolol was not changed, No
changes were observed when dobutamine (a beta(1)-selective adrenocepto
r agonist) and clonidine (an alpha(2)-adrenoceptor agonist) were used,
3, The basal lipolysis rates decreased by about 50% after weight redu
ction and the maximum enzyme activity of hormone-sensitive lipase was
also reduced by almost 50%. 4, Plasma concentrations of insulin, norad
renaline and total testosterone decreased and sex hormone-binding glob
ulin increased after weight reduction, Calculated apparent free testos
terone levels decreased by more than 40% after weight reduction. 5. In
conclusion, weight reduction leads to increased efficiency of adipocy
te lipolysis with decreased resting lipolysis rate but increased sensi
tivity to stimulation by catecholamines, which may be attributed to a
decreased activity of hormone-sensitive lipase and an increased sensit
ivity of beta(2)-adrenoceptors. Changes in circulating levels of catec
holamines, insulin and testosterone may play a role in these modificat
ions of adipocyte function, The increased lipolytic efficiency may be
of importance for amelioration of the metabolic complications of obesi
ty that are observed after weight reduction.